Furthermore, during therapeutic vaccination of mice bearing IL-10-expressing tumors, we have recently reported the relevance of vaccine-induced IL-10, as opposed to that derived from the tumor, demonstrating its importance in the control of T-cell activation and in the therapeutic efficacy of vaccines [23]. This evidence concerns the gene IL10 and neoplasm.